INS and metabolic syndrome: Growing evidence from both cell culture, animal, and human studies suggests that NAC may offer therapeutic benefits in MetS-associated comorbidities, including CVD, by improving redox balance, glucose metabolism, insulin sensitivity, lipid metabolism, and inflammation, although some data seem contradictory, and a more in-depth analysis is surely necessary to fully understand NAC’s actions (summarized in Table 1).